Abstract: A medicinal composition for treating acid reflux disease comprises an effective amount of a pharmaceutical and an effective amount of a nutraceutical in a pharmaceutically acceptable base. The pharmaceutical is an acid-controlling pharmaceutical, such as cimetidine or ranitidine. The nutraceutical is a nutraceutical which is useful for treating stomach disorders, a nutraceutical which protects the mucosal linings of the digestive system, or a liver protectants. A method of using such a cmposition in the treatment of acid reflex disease is also disclosed.

Abstract: A hair cleanser of the following formula: 5.00 to 10.00% by weight aloe vera gel; 2.00 to 5.00% by weight glycerin; 1.00 to 3.00% by weight behentrimonium chloride; 1.00 to 3.00% by weight stearamidepropyl dimethyamine; 1.00 to 3.00% by weight cetyl alcohol; 1.00 to 3.00% by weight emulsifying wax; 0.10 to 1.00% by weight panthenol; 0.10 to 1.00% by weight trimethylsilylamodimethicone; 0.10 to 1.00% by weight hydrolyzed whole wheat protein 0.10 to 1.00% by weight PEG-60 almond glycerides; 0.10 to 0.50% by weight menthol; 0.10 to 0.50% by weight peppermint oil;; 0.10 to 0.50% by weight sweet almond oil; 0.10 to 0.50% by weight chamomile extract; 0.10 to 0.50% by weight cherry bark extract; 0.10 to 0.50% by weight calendula extract; 0.10 to 0.50% by weight rosemary extract; 0.10 to 0.50% by weight citric acid; 0.10 to 0.50% by weight methylchoroisothiazolinone and methyliosothiazolinone; 0.10 to 0.50% by weight fragrance; and water.

Abstract: A therapeutic composition having plantain and aloe vera constituents is useful in the treatment of the symptoms of arthritis and other afflictions. The therapeutic composition may have only plantain and aloe vera constituents, wherein the plantain constituent is in a range of approximately 57% to 61% by weight of the therapeutic composition and the aloe vera constituent is in a range of approximately 39% to 43% by weight of the therapeutic composition. The therapeutic composition may have other constituents, such as herbal tinctures, added for various purposes, in which case, the plantain constituent is in a range of approximately 51% to 58% by weight of the therapeutic composition, the aloe vera constituent is in a range of approximately 37% to 39% by weight of the therapeutic composition, and the other constituent is in the range of approximately 5% to 10% by weight of the therapeutic composition.

Abstract: The present invention relates to cosmetic formulations for topical application containing extracts from Phyllanthus emblica and Centella asiatica and/or Bacopa monnieri, and the use of such formulations for the care of the human skin.

Abstract: The present invention provides a rapid and efficient method for the preparation and isolation of biologically active polysaccharides from Aloe. The present invention includes the activated mixture of polysaccharides (referred to herein as “Inmuno-10”), produced by the methods of the invention. The invention also includes the use of the polysaccharides as immunostimulating, immunomodulating and wound healing agents. The resulting immunomodulatory complex has a higher activity and is more stable than bulk carbohydrates isolated using prior art alcohol precipitation schemes.

Abstract: The present invention relates to cosmetic formulations for topical application containing extracts from Phyllanthus emblica and Centella asiatica and/or Bacopa monnieri, and the use of such formulations for the care of the human skin. In particular, the present invention relates to cosmetic formulations for topical application containing extracts from Phyllanthus emblica and Centella asiatica and/or Bacopa monnieri in addition to per se known adjuvants and expedients.

Abstract: The present invention provides a novel vehicle for the delivery of biologically active agents. The vehicle, Maxcell™, is formulated from a novel combination of natural plant extracts and is comprised of Aloe vera polysaccharide fraction Immuno-10, cAMP, piperine, calcium phosphate and glycyrrhizinic acid.

Abstract: A method of increasing the bulk density and improving the water-dispersibility, oil sorption capacity, and body dirt and oil removability by compacting and/or shearing a magnesium rich calcium montmorillonite clay. In an optional embodiment of the present invention, silica gel, sodium silicate, acrylic polymers and copolymers, carboxy methyl cellulose, or other materials capable of providing lubricity to the surface of the clay crystals is added to the clay, prior to shearing, to enhance the compaction and/or shearing process and further increase the bulk density of the clay. The clay is sheared in an extruder, pug mill or California-type pellet mill when the clay includes about 20% to about 45%, preferably about 25% to about 40% by weight water, based on the dry weight of the clay.